首页|TET2抑制剂衣康酸对乳腺癌细胞增殖、迁移的影响

TET2抑制剂衣康酸对乳腺癌细胞增殖、迁移的影响

扫码查看
目的 探讨甲基胞嘧啶双加氧酶2(TET2)抑制剂衣康酸对乳腺癌细胞株MDA-MB-231增殖、迁移的影响及机制。方法 人乳腺癌细胞株MDA-MB-231分别采用二甲基亚砜(DMSO)和1、5 µmol/L衣康酸处理24 h,流式细胞术检测细胞凋亡确定可用的衣康酸浓度,免疫荧光实验检测衣康酸对细胞5-羟甲基胞嘧啶(5hmC)表达水平的抑制作用,细胞计数、MTS检测衣康酸对细胞增殖和活性的影响,Transwell实验检测衣康酸对细胞迁移能力的影响,甲基化特异性实时荧光定量PCR(qPCR)检测衣康酸处理对细胞增殖、迁移相关基因启动子区甲基化的影响,qPCR检测衣康酸对细胞增殖、迁移相关基因表达的影响。结果 5 μmol/L衣康酸处理细胞对细胞凋亡均无明显影响,且可抑制5hmC表达水平(P<0。05)。细胞计数和MTS结果表明,衣康酸促进细胞增殖(增加约58%,P<0。05),增强细胞活性(增加约42%,P<0。05);Transwell实验结果表明,衣康酸增强细胞迁移(增加约55%,P<0。05)。甲基化特异性qPCR结果表明,衣康酸处理明显促进p21和PTEN启动子甲基化(P<0。05)。qPCR结果表明,衣康酸明显抑制p21和PTEN表达水平(P<0。05)。结论 衣康酸通过抑制p21和PTEN的5hmC水平降低其表达,促进MDA-MB-231乳腺癌细胞的增殖、迁移。
Effect of TET2 inhibitor itaconate on proliferation and migration of breast cancer cells
Objective To investigate the effects and mechanism of TET2 inhibitor itaconate in prolifer-ation and migration of breast cancer cell line MDA-MB-231.Methods The MDA-MB-231 cells were treated for 24 h with dimethyl sulfoxide(DMSO)and 1,5 μmol/L itaconate respectively.The cellular apoptosis was determined by flow cytometry to determine the available itaconic acid concentration.The immunofluorescence was performed to determine the inhibiting effect of itaconate on hydroxymethylcytosine(5hmC)expression level.The cell counting and MTS were performed to determine the effect of itaconate on cell proliferation and activity.The Transwell experiment was performed to determine the effect of itaconate on cell transfer ability.The methylation-specific real-time fluorescence quantitative PCR(qPCR)was used to detect the effects of ita-conic acid treatment on the methylation of promoter regions of genes related to cell proliferation and migra-tion.qPCR was used to detect the effects of itaconate on the cellular proliferation,migration related genes ex-pression.Results 5 μmol/L itaconate treating the cells had no significant effect on the cellular apoptosis,mo-reover could inhibit 5hmC expression level.The cell count and MTS results showed that itaconate could pro-mote the cell proliferation(increase by about 58%,P<0.05)and increase the cell activity(increase by 42%,P<0.05).The Transwell experiment results showed that itaconate increased the cell migration(increase by 55%,P<0.05).The methylation-specific qPCR showed that the itaconate treatment significantly promoted the methyaltion of the promoters p21 and PTEN.The qPCR results showed that itaconate significantly inhibi-ted the expression levels of p21 and PTEN(P<0.05).Conclusion Itaconate promotes the proliferation and migration of MDA-MB-231 cells through inhibiting 5hmC level of p21 and PTEN and decrease its expression.

breast canceritaconateDNA methylationproliferationmigration5hmC

曾俊杰、熊忠讯、莫绍江、张辉

展开 >

重庆大学附属肿瘤医院,肿瘤转移与个体化诊治转化研究重庆市重点实验室,重庆 400030

乳腺癌 衣康酸 DNA甲基化 增殖 迁移 5-羟甲基胞嘧啶

2024

重庆医学
重庆市卫生信息中心,重庆市医学会

重庆医学

CSTPCD
影响因子:1.797
ISSN:1671-8348
年,卷(期):2024.53(17)